Back

Temporal trends in treatment patterns, morbidity, and mortality in patients with new-onset heart failure compared to heart failure survivors: a nationwide 23-year perspective

30 August 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Outcomes in heart failure: a global perspective Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Emma Kidholm Boysen

Copenhagen (Denmark)

8 More presentations in this session

Presentation thumbnail
Prognostic value of myocardial redox signalling: a machine learning multi-omics approach
Doctor I. Badi (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Protein signatures associated with methylation patterns of heart failure phenotypes
Mr M. Krolevets (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
20 year picture of a heart failure clinic: changes in the patients profiles' and 2-year mortality.
Miss A. Carrete (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Temporal trends in clinical outcomes in heart failure patients with and without atrial fibrillation: a nationwide study from 1997-2018
Ms M. Austreim (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Resting heart rate and outcomes in patients with heart failure: impact of AF from the Thai-Heat Failure Registry (THFR - HRAF study)
Doctor A. Ariyachaipanich (Bangkok, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes in heart failure: a global perspective

The Event

Event poster

ESC Congress 2024

30 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Outpatient prescribing of guideline-directed medical therapy in heart failure
thumbnail
Congress Presentation
Initiation, titration, and discontinuation - utilization of heart failure medicines in England (EVOLUTION HF UK)
thumbnail
Congress Presentation
Disparities in clinical characteristics, treatment, and prognosis among immigrants and native patients in Denmark with new-onset heart failure and reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources